IDBS and Scitara form strategic partnership

By The Science Advisory Board staff writers

June 8, 2021 -- Biopharmaceutical lifecycle management technology provider IDBS and Scitara have inked a strategic partnership agreement.

Under the deal, Scitara's Digital Lab Exchange (DLX) platform will be integrated with IDBS' Polar pharmaceutical lifecycle management software platform, according to the companies.

Designed to address the challenge of sharing and digitalizing laboratory data across the biopharmaceutical lifecycle, the combined package will enable IDBS customers to gain connectivity to any instrument or application in regulated and nonregulated laboratories, the firms said.

Scitara raises $5M to develop its DLX platform
Scitara has raised $5 million in series A financing that it plans to use to fully develop its Digital Lab Exchange (DLX) platform.

Copyright © 2021

International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter